메뉴 건너뛰기




Volumn 11, Issue 10, 2014, Pages 597-606

Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR ANTAGONIST; TICAGRELOR; UNCLASSIFIED DRUG;

EID: 84925944305     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.104     Document Type: Review
Times cited : (289)

References (82)
  • 3
    • 84856158305 scopus 로고    scopus 로고
    • ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-segment Elevation of the European Society of Cardiology (ESC)
    • Hamm, C. W. et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-segment Elevation of the European Society of Cardiology (ESC). Eur. Heart J. 32, 2999-3054 (2011).
    • (2011) Eur. Heart J. , vol.32 , pp. 2999-3054
    • Hamm, C.W.1
  • 4
    • 83155180256 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
    • Levine, G. N. et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 124, e574-e651 (2011).
    • (2011) Circulation , vol.124 , pp. e574-e651
    • Levine, G.N.1
  • 5
    • 84872698656 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • O'Gara, P. T. et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 61, e78-e140 (2013).
    • (2013) J. Am. Coll. Cardiol. , vol.61 , pp. e78-e140
    • O'Gara, P.T.1
  • 6
    • 77958128969 scopus 로고    scopus 로고
    • Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
    • Wijns, W. et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 31, 2501-2555 (2010).
    • (2010) Eur. Heart J. , vol.31 , pp. 2501-2555
    • Wijns, W.1
  • 7
    • 84865271531 scopus 로고    scopus 로고
    • 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Jneid, H. et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 126, 875-910 (2012).
    • (2012) Circulation , vol.126 , pp. 875-910
    • Jneid, H.1
  • 8
    • 84890025521 scopus 로고    scopus 로고
    • Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
    • Tantry, U. S. et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J. Am. Coll. Cardiol. 62, 2261-2273 (2013).
    • (2013) J. Am. Coll. Cardiol. , vol.62 , pp. 2261-2273
    • Tantry, U.S.1
  • 9
    • 84896551095 scopus 로고    scopus 로고
    • East Asian paradox": Challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome
    • Jeong, Y.-H. "East Asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome. Curr. Cardiol. Rep. 16, 485 (2014).
    • (2014) Curr. Cardiol. Rep. , vol.16 , pp. 485
    • Jeong, Y.-H.1
  • 10
    • 62949144502 scopus 로고    scopus 로고
    • Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization. Management, and Avoidance (CHARISMA) study
    • Mak, K. H. et al. Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. Am. Heart J. 157, 658-665 (2009).
    • (2009) Am. Heart J. , vol.157 , pp. 658-665
    • Mak, K.H.1
  • 11
    • 34447333944 scopus 로고    scopus 로고
    • Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
    • Shen, A. Y., Yao, J. F., Brar, S. S., Jorgensen, M. B., Chen, W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J. Am. Coll. Cardiol. 50, 309-315 (2007).
    • (2007) J. Am. Coll. Cardiol. , vol.50 , pp. 309-315
    • Shen, A.Y.1    Yao, J.F.2    Brar, S.S.3    Jorgensen, M.B.4    Chen, W.5
  • 12
    • 33745139842 scopus 로고    scopus 로고
    • Proportions of stroke subtypes among men and women > or = 40 years of age in an urban Japanese city in 1992, 1997, and 2002
    • Kitamura, A. et al. Proportions of stroke subtypes among men and women > or = 40 years of age in an urban Japanese city in 1992, 1997, and 2002. Stroke 37, 1374-1378 (2006).
    • (2006) Stroke , vol.37 , pp. 1374-1378
    • Kitamura, A.1
  • 13
    • 17744374250 scopus 로고    scopus 로고
    • The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
    • Mehta, S. R., Yusuf, S. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur. Heart J. 21, 2033-2041 (2000).
    • (2000) Eur. Heart J. , vol.21 , pp. 2033-2041
    • Mehta, S.R.1    Yusuf, S.2
  • 14
    • 84858430231 scopus 로고    scopus 로고
    • Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents? the role of platelet reactivity and genotype testing in the prevention of atherothrombotic cardiovascular events remains unproven
    • Krishna, V., Diamond, G. A., Kaul, S. Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents? The role of platelet reactivity and genotype testing in the prevention of atherothrombotic cardiovascular events remains unproven. Circulation 125, 1288-1303 (2012).
    • (2012) Circulation , vol.125 , pp. 1288-1303
    • Krishna, V.1    Diamond, G.A.2    Kaul, S.3
  • 15
    • 84858407916 scopus 로고    scopus 로고
    • Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents? Platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents
    • Gurbel, P. A., Tantry, U. S. Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents? Platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents. Circulation 125, 1276-1287 (2012).
    • (2012) Circulation , vol.125 , pp. 1276-1287
    • Gurbel, P.A.1    Tantry, U.S.2
  • 17
    • 69949122850 scopus 로고    scopus 로고
    • Prasugrel in clinical practice
    • Bhatt, D. L. Prasugrel in clinical practice. N. Engl. J. Med. 361, 940-94 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , pp. 940-994
    • Bhatt, D.L.1
  • 18
    • 37349111065 scopus 로고    scopus 로고
    • Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial
    • Wiviott, S. D. et al. Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 116, 2923-2932 (2007).
    • (2007) Circulation , vol.116 , pp. 2923-2932
    • Wiviott, S.D.1
  • 19
    • 75549086129 scopus 로고    scopus 로고
    • Antiplatelet therapy: Ticagrelor in ACS-what does PLATO teach us?
    • Bhatt, D. L. Antiplatelet therapy: Ticagrelor in ACS-what does PLATO teach us? Nat. Rev. Cardiol. 6, 737-738 (2009).
    • (2009) Nat. Rev. Cardiol. , vol.6 , pp. 737-738
    • Bhatt, D.L.1
  • 20
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf, S. et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345, 494-502 (2001).
    • (2001) N. Engl. J. Med. , vol.345 , pp. 494-502
    • Yusuf, S.1
  • 21
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta, S. R. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358, 527-533 (2001).
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1
  • 22
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Steinhubl, S. R. et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288, 2411-2420 (2002).
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1
  • 23
    • 33644587565 scopus 로고    scopus 로고
    • Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention
    • Steinhubl, S. R., Berger, P. B., Brennan, D. M., Topol, E. J. Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention. J. Am. Coll. Cardiol. 47, 939-943 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.47 , pp. 939-943
    • Steinhubl, S.R.1    Berger, P.B.2    Brennan, D.M.3    Topol, E.J.4
  • 24
    • 27644548513 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: Randomised placebo-controlled trial
    • Chen, Z. M. et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366, 1607-1621 (2005).
    • (2005) Lancet , vol.366 , pp. 1607-1621
    • Chen, Z.M.1
  • 25
    • 36148983750 scopus 로고    scopus 로고
    • Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001-2015 (2007).
    • (2007) N. Engl. J. Med. , vol.357 , pp. 2001-2015
    • Wiviott, S.D.1
  • 26
    • 55949103494 scopus 로고    scopus 로고
    • Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38
    • Wiviott, S. D. et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 118, 1626-1636 (2008).
    • (2008) Circulation , vol.118 , pp. 1626-1636
    • Wiviott, S.D.1
  • 27
    • 84867177857 scopus 로고    scopus 로고
    • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
    • Roe, M. T. et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N. Engl. J. Med. 367, 1297-1309 (2012).
    • (2012) N. Engl. J. Med. , vol.367 , pp. 1297-1309
    • Roe, M.T.1
  • 28
    • 70149101223 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045-1057 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , pp. 1045-1057
    • Wallentin, L.1
  • 29
    • 82255188048 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: Substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
    • James, S. K. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ 342, d3527 (2011).
    • (2011) BMJ , vol.342 , pp. d3527
    • James, S.K.1
  • 30
    • 84862146372 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack
    • James, S. K. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack. Circulation 125, 2914-2921 (2012).
    • (2012) Circulation , vol.125 , pp. 2914-2921
    • James, S.K.1
  • 31
    • 80051550924 scopus 로고    scopus 로고
    • Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
    • Mahaffey, K. W. et al. Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 124, 544-554 (2011).
    • (2011) Circulation , vol.124 , pp. 544-554
    • Mahaffey, K.W.1
  • 32
    • 85028148651 scopus 로고    scopus 로고
    • Center for Drug Evaluation and Research. Brilinta REMS document. NDA 22-433 [online]
    • Center for Drug Evaluation and Research. Brilinta REMS document. NDA 22-433 [online], http://www.accessdata.fda.gov/drugsatfda-docs/nda/2011/022433Orig1s000REMS.pdf (2011).
    • (2011)
  • 33
    • 84885217467 scopus 로고    scopus 로고
    • ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction
    • Anderson, J. L. et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation 127, e663-e828 (2013).
    • (2012) Circulation , vol.127 , pp. e663-e828
    • Anderson, J.L.1
  • 34
    • 77958128969 scopus 로고    scopus 로고
    • Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
    • Kolh, P. et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 31, 2501-2555 (2010).
    • (2010) Eur. Heart J. , vol.31 , pp. 2501-2555
    • Kolh, P.1
  • 35
    • 84883170442 scopus 로고    scopus 로고
    • Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update
    • Scott, S. A. et al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin. Pharmacol. Ther. 94, 317-323 (2013).
    • (2013) Clin. Pharmacol. Ther. , vol.94 , pp. 317-323
    • Scott, S.A.1
  • 36
    • 84880573335 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males
    • Yu, K. S. et al. Pharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males. J. Cardiovasc. Pharmacol. 62, 72-77 (2013).
    • (2013) J. Cardiovasc. Pharmacol. , vol.62 , pp. 72-77
    • Yu, K.S.1
  • 37
    • 84868531128 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects
    • Cui, Y. M. et al. Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects. Acta Pharmacol. Sin. 33, 1395-1400 (2012).
    • (2012) Acta Pharmacol. Sin. , vol.33 , pp. 1395-1400
    • Cui, Y.M.1
  • 38
    • 79953817883 scopus 로고    scopus 로고
    • Integrated analysis of pharmacokinetic data across multiple clinical pharmacology studies of prasugrel, a new thienopyridine antiplatelet agent
    • Small, D. S., et al. Integrated analysis of pharmacokinetic data across multiple clinical pharmacology studies of prasugrel, a new thienopyridine antiplatelet agent. J. Clin. Pharmacol. 51, 321-332 (2011).
    • (2011) J. Clin. Pharmacol. , vol.51 , pp. 321-332
    • Small, D.S.1
  • 39
    • 77649332028 scopus 로고    scopus 로고
    • Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: An open-label trial
    • Small, D. S. et al. Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial. Clin. Ther. 32, 365-379 (2010).
    • (2010) Clin. Ther. , vol.32 , pp. 365-379
    • Small, D.S.1
  • 40
    • 76949099975 scopus 로고    scopus 로고
    • The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects
    • Small, D. S. et al. The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects. Eur. J. Clin. Pharmacol. 66, 127-135 (2010).
    • (2010) Eur. J. Clin. Pharmacol. , vol.66 , pp. 127-135
    • Small, D.S.1
  • 41
    • 84860427595 scopus 로고    scopus 로고
    • Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention
    • Yokoi, H., Kimura, T., Isshiki, T., Ogawa, H., Ikeda, Y. Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention. Thromb. Res. 129, 623-628 (2012).
    • (2012) Thromb. Res. , vol.129 , pp. 623-628
    • Yokoi, H.1    Kimura, T.2    Isshiki, T.3    Ogawa, H.4    Ikeda, Y.5
  • 42
    • 84876750493 scopus 로고    scopus 로고
    • Pharmacodynamic comparisons for single loading doses of prasugrel (30 mg) and clopidogrel (600 mg) in healthy Korean volunteers
    • Kim, M. H., Zhang, H. Z., Jung, D, K. Pharmacodynamic comparisons for single loading doses of prasugrel (30 mg) and clopidogrel (600 mg) in healthy Korean volunteers. Circ. J. 77, 1253-1259 (2013).
    • (2013) Circ. J. , vol.77 , pp. 1253-1259
    • Kim, M.H.1    Zhang, H.Z.2    Jung, D.K.3
  • 43
    • 84855430534 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: An open-label, sequential, two-cohort, single-centre study
    • Li, H., Butler, K., Yang, L., Yang, Z., Teng R. Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study. Clin. Drug Investig. 32, 87-97 (2012).
    • (2012) Clin. Drug Investig. , vol.32 , pp. 87-97
    • Li, H.1    Butler, K.2    Yang, L.3    Yang, Z.4    Teng, R.5
  • 44
    • 84902135631 scopus 로고    scopus 로고
    • Pharmacokinetics pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers
    • Teng, R., Butler, K. Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers. Int. J. Clin. Pharmacol. Ther. 52, 478-491 (2014).
    • (2014) Int. J. Clin. Pharmacol. Ther. , vol.52 , pp. 478-491
    • Teng, R.1    Butler, K.2
  • 46
    • 24044552753 scopus 로고    scopus 로고
    • Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: From the Clopidogrel for the Reduction of Events during Observation (CREDO) trial
    • Beinart, S. C. et al. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. J. Am. Coll. Cardiol. 46, 761-769 (2005).
    • (2005) J. Am. Coll. Cardiol. , vol.46 , pp. 761-769
    • Beinart, S.C.1
  • 47
    • 14844330753 scopus 로고    scopus 로고
    • Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial
    • Sabatine, M. S., McCabe, C. H., Gibson, C. M., Cannon, C. P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial. Am. Heart J. 149, 227-233 (2005).
    • (2005) Am. Heart J. , vol.149 , pp. 227-233
    • Sabatine, M.S.1    McCabe, C.H.2    Gibson, C.M.3    Cannon, C.P.4
  • 48
    • 84920785784 scopus 로고    scopus 로고
    • Net clinical benefits of ticagrelor compared with clopidogrel in Asian acute coronary syndrome patients: A PLATO sub-study [abstract]
    • Kang, H.-J. et al. Net clinical benefits of ticagrelor compared with clopidogrel in Asian acute coronary syndrome patients: a PLATO sub-study [abstract]. Circulation 128, A17001 (2013).
    • (2013) Circulation , vol.128 , pp. A17001
    • Kang, H.-J.1
  • 49
    • 84903208627 scopus 로고    scopus 로고
    • Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study
    • Saito, S. et al. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ. J. 78, 1684-1692 (2014).
    • (2014) Circ. J. , vol.78 , pp. 1684-1692
    • Saito, S.1
  • 51
    • 65349083830 scopus 로고    scopus 로고
    • The CYP2C192 and CYP2C193 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome
    • Kim, I. S., Choi, B. R., Jeong, Y. H., Kwak, C. H., Kim, S. The CYP2C192 and CYP2C193 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome. J. Thromb. Haemost. 7, 897-899 (2009).
    • (2009) J. Thromb. Haemost. , vol.7 , pp. 897-899
    • Kim, I.S.1    Choi, B.R.2    Jeong, Y.H.3    Kwak, C.H.4    Kim, S.5
  • 52
    • 84880907304 scopus 로고    scopus 로고
    • The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: Outcomes in patients with acute coronary syndrome after drug-eluting stent implantation
    • Liang, Z. Y. et al. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention 9, 316-327 (2013).
    • (2013) Euro Intervention , vol.9 , pp. 316-327
    • Liang, Z.Y.1
  • 53
    • 84866765277 scopus 로고    scopus 로고
    • Prevalence of CYP2C19 polymorphisms involved in clopidogrel metabolism in Fujian Han population [Chinese]
    • Wei, W. et al. Prevalence of CYP2C19 polymorphisms involved in clopidogrel metabolism in Fujian Han population [Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29, 420-425 (2012).
    • (2012) Zhonghua Yi Xue Yi Chuan Xue Za Zhi , vol.29 , pp. 420-425
    • Wei, W.1
  • 54
    • 80052573217 scopus 로고    scopus 로고
    • Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: A time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial
    • Price, M. J. et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation 124, 1132-1137 (2011).
    • (2011) Circulation , vol.124 , pp. 1132-1137
    • Price, M.J.1
  • 55
    • 79851485451 scopus 로고    scopus 로고
    • Comparison of 2 point-of-care platelet function tests, VerifyNow assay and multiple electrode platelet aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention
    • Ko, Y. G. et al. Comparison of 2 point-of-care platelet function tests, VerifyNow assay and multiple electrode platelet aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention. Am. Heart J. 161, 383-390 (2011).
    • (2011) Am. Heart J. , vol.161 , pp. 383-390
    • Ko, Y.G.1
  • 56
    • 78651287537 scopus 로고    scopus 로고
    • Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: Results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy on ischemic complication after drug-eluting stenT implantation) trial
    • Suh, J. W. et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. J. Am. Coll. Cardiol. 57, 280-289 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.57 , pp. 280-289
    • Suh, J.W.1
  • 57
    • 84863338161 scopus 로고    scopus 로고
    • Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction
    • Ahn, S. G. et al. Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction. JACC Cardiovasc. Interv. 5, 259-267 (2012).
    • (2012) JACC Cardiovasc. Interv. , vol.5 , pp. 259-267
    • Ahn, S.G.1
  • 58
    • 84875915732 scopus 로고    scopus 로고
    • Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: Results in 423, 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare, Medicaid services payer databases
    • Kumar, R. S. et al. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423, 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare, Medicaid services payer databases. Circulation 127, 1395-1403 (2013).
    • (2013) Circulation , vol.127 , pp. 1395-1403
    • Kumar, R.S.1
  • 59
    • 33847167065 scopus 로고    scopus 로고
    • Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
    • Daemen, J. et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369, 667-678 (2007).
    • (2007) Lancet , vol.369 , pp. 667-678
    • Daemen, J.1
  • 60
    • 61849093662 scopus 로고    scopus 로고
    • Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation
    • Kimura, T. et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119, 987-995 (2009).
    • (2009) Circulation , vol.119 , pp. 987-995
    • Kimura, T.1
  • 61
    • 54149089301 scopus 로고    scopus 로고
    • Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents
    • Park, D. W. et al. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. JACC Cardiovasc. Interv. 1, 494-503 (2008).
    • (2008) JACC Cardiovasc. Interv. , vol.1 , pp. 494-503
    • Park, D.W.1
  • 62
    • 33344478392 scopus 로고    scopus 로고
    • Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66, 155 cases and 91, 307 controls
    • Ye, Z. et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66, 155 cases and 91, 307 controls. Lancet 367, 651-658 (2006).
    • (2006) Lancet , vol.367 , pp. 651-658
    • Ye, Z.1
  • 63
    • 33750973936 scopus 로고    scopus 로고
    • Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: The MESA study
    • Lutsey, P. L. et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J. Thromb. Haemost. 4, 2629-2635 (2006).
    • (2006) J. Thromb. Haemost. , vol.4 , pp. 2629-2635
    • Lutsey, P.L.1
  • 64
    • 44849111250 scopus 로고    scopus 로고
    • Ethnic differences in C-reactive protein concentrations
    • Kelley-Hedgepeth, A. et al. Ethnic differences in C-reactive protein concentrations. Clin. Chem. 54, 1027-1037 (2008).
    • (2008) Clin. Chem. , vol.54 , pp. 1027-1037
    • Kelley-Hedgepeth, A.1
  • 65
    • 80053575777 scopus 로고    scopus 로고
    • First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: Possible relationship to the Japanese paradox"
    • Gorog, D. A. et al. First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: possible relationship to the "Japanese paradox". Int. J. Cardiol. 152, 43-48 (2011).
    • (2011) Int. J. Cardiol. , vol.152 , pp. 43-48
    • Gorog, D.A.1
  • 66
    • 77950681902 scopus 로고    scopus 로고
    • Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents
    • Tsukahara, K. et al. Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents. Circ. J. 74, 679-685 (2010).
    • (2010) Circ. J. , vol.74 , pp. 679-685
    • Tsukahara, K.1
  • 67
    • 84901413293 scopus 로고    scopus 로고
    • Correlation between platelet reactivity and type of post-discharge bleeding events in PCI-treated patients: Result of the ACCEL-BLEED study [abstract]
    • Jeong, Y.-H. et al. Correlation between platelet reactivity and type of post-discharge bleeding events in PCI-treated patients: result of the ACCEL-BLEED study [abstract]. J. Am. Coll. Cardiol. 58 (Suppl. 1), B221 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.58 , pp. B221
    • Jeong, Y.-H.1
  • 68
    • 85028166975 scopus 로고    scopus 로고
    • US National Library of Medicine. ClinicalTrials.gov [online]
    • US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/study/NCT01361386 (2013).
    • (2013)
  • 69
    • 84920785781 scopus 로고    scopus 로고
    • Contemporary pre-hospital management of acute coronary syndromes patients: Results from the EPICOR Asia study [abstract]
    • Huo, Y. et al. Contemporary pre-hospital management of acute coronary syndromes patients: results from the EPICOR Asia study [abstract]. Circulation 128, A14546 (2013).
    • (2013) Circulation , vol.128 , pp. A14546
    • Huo, Y.1
  • 70
    • 84884214106 scopus 로고    scopus 로고
    • Guidelines for the management of acute STEMI
    • Chinese Society of Cardiology
    • Chinese Society of Cardiology. Guidelines for the management of acute STEMI. Chin. J. Cardiol. 38, 675-690 (2010).
    • (2010) Chin. J. Cardiol. , vol.38 , pp. 675-690
  • 71
    • 84920775028 scopus 로고    scopus 로고
    • Guidelines for the management of NSTE ACS
    • Chinese Society of Cardiology
    • Chinese Society of Cardiology. Guidelines for the management of NSTE ACS. Chin. J. Cardiol. 40, 353-367 (2012).
    • (2012) Chin. J. Cardiol. , vol.40 , pp. 353-367
  • 73
    • 70549084813 scopus 로고    scopus 로고
    • Antiplatelet therapy after coronary intervention in Asia and Japan: The Asian perspective of antiplatelet intervention
    • Goto, S., Toda, E. Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention. Hamostaseologie 29, 321-325 (2009).
    • (2009) Hamostaseologie , vol.29 , pp. 321-325
    • Goto, S.1    Toda, E.2
  • 74
    • 85028172608 scopus 로고    scopus 로고
    • [online]
    • Korean guideline for antiplatelet selection in ACS patients [online], http://www.kaim.or.kr/main/files/%ED%95%AD%ED%98%88%EC%86%8C%ED%8C%90%EC%A0%9C-%ED%88%AC%EC%97%AC%EC%9A%94%EB%B2%95-%EA%B6%8C%EA%B3%A0%EC%95%88.pdf (2014).
    • (2014) Korean Guideline for Antiplatelet Selection in ACS Patients
  • 75
    • 20144373281 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
    • Sabatine, M. S. et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N. Engl. J. Med. 352, 1179-1189 (2005).
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1179-1189
    • Sabatine, M.S.1
  • 76
    • 24644495673 scopus 로고    scopus 로고
    • Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: The PCI-CLARITY study
    • Sabatine, M. S. et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 294, 1224-1232 (2005).
    • (2005) JAMA , vol.294 , pp. 1224-1232
    • Sabatine, M.S.1
  • 77
    • 9244251971 scopus 로고    scopus 로고
    • A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
    • Schömig, A. et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N. Engl. J. Med. 334, 1084-1089 (1996).
    • (1996) N. Engl. J. Med. , vol.334 , pp. 1084-1089
    • Schömig, A.1
  • 78
    • 0032481092 scopus 로고    scopus 로고
    • A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting
    • Leon, M. B. et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N. Engl. J. Med. 339, 1665-1671 (1998).
    • (1998) N. Engl. J. Med. , vol.339 , pp. 1665-1671
    • Leon, M.B.1
  • 79
    • 77958005516 scopus 로고    scopus 로고
    • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
    • Mehta, S. R. et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 376, 1233-1243 (2010).
    • (2010) Lancet , vol.376 , pp. 1233-1243
    • Mehta, S.R.1
  • 81
    • 79952598836 scopus 로고    scopus 로고
    • Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial
    • Price, M. J. et al. Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305, 1097-1105 (2011).
    • (2011) JAMA , vol.305 , pp. 1097-1105
    • Price, M.J.1
  • 82
    • 84870032410 scopus 로고    scopus 로고
    • Bedside monitoring to adjust antiplatelet therapy for coronary stenting
    • Collet, J. P. et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N. Engl. J. Med. 367, 2100-2109 (2012).
    • (2012) N. Engl. J. Med. , vol.367 , pp. 2100-2109
    • Collet, J.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.